Results of AGM
Released
Released
Announcement PDF
ASX Release
29 November 2023
Results of Annual General Meeting
Melbourne, Australia; Acrux Limited (ASX:ACR): The results of the Annual General Meeting
held on 29 November 2023 are set out in the attached document.
All resolutions were decided by poll with Resolutions 1, 2, 4 and 5 passed as ordinary resolutions
and Resolution 3 passed as a special resolution.
As Resolution 5: Adoption of Remuneration was supported by more than 75% votes cast,
Resolution 6: Conditional Spill Resolution was not required to be put to the meeting.
Authorised for release by the Board of Acrux Limited.
For more information, please contact:
Michael Kotsanis
Acrux Limited
CEO & Managing Director
P: + 61 3 8379 0100
E: michael.kotsanis@acrux.com.au
About Acrux
Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising
topical pharmaceuticals. Drawing on 25 years of experience and using in house facilities and
capabilities, Acrux has successfully developed and commercialised through licensees a number
of topically applied pharmaceutical products in the US and Europe. Acrux is developing of a
range of generic products for the US market by leveraging its on-site laboratories, GMP
manufacturing suite, clinical and commercial experience to bring affordable products to market.
Acrux encourages collaboration and is well positioned to discuss partnering and product
development.
For further information on Acrux, visit www.acrux.com.au
ACRUX LIMITED
RESULT OF ANNUAL GENERAL
MEETING (ASX REPORT)
ANNUAL GENERAL MEETING
Wednesday, 29 November, 2023
As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda.
Resolution Voted on at the meeting
No
1
2
3
4
5
6
Proxy Votes (as at proxy close)
Total votes cast in the poll (where applicable)
Strike
Y/N/NA
For
Against
Discretionary
(open votes)
Abstain
For
Against
Abstain **
Result
RE-ELECTION OF MR ROSS DOBINSON AS A
DIRECTOR
NA
47,208,051
4,246,811
995,272
5,578,885
50,102,913
4,537,894
5,578,885
Carried
90.01%
8.10%
1.90%
91.70%
8.30%
ISSUE OF RIGHTS TO NON-EXECUTIVE DIRECTORS
AS A COMPONENT OF THEIR REMUNERATION
NA
37,899,548
8,796,360
1,461,320
39,627,345
9,087,443
2,286,245
Carried
78.70%
18.27%
3.03%
81.35%
18.65%
APPROVAL OF 10% PLACEMENT CAPACITY - SHARES
NA
47,010,704
8,173,699
1,572,491
50,773,868
8,173,699
1,272,125
Carried
82.83%
14.40%
2.77%
86.13%
13.87%
37,054,517
7,764,021
1,471,820
39,017,420
7,764,021
2,742,032
Carried
80.05%
16.77%
3.18%
83.40%
16.60%
39,826,175
5,762,282
1,161,320
41,478,578
5,762,282
2,282,613
Carried
85.19%
12.33%
2.48%
87.80%
12.20%
Not put to Meeting
Not put to Meeting
Not put to Meeting
Not put to
Meeting
Short Description
APPROVAL OF OMNIBUS EQUITY PLAN TO
REFRESH APPROVAL AS REQUIRED BY THE ASX
LISTING RULES
NA
ADOPTION OF REMUNERATION REPORT
N
CONDITIONAL SPILL RESOLUTION
2,286,245
1,272,125
2,742,032
2,282,613
NA
** - Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item
Printed:
29/11/2023
This report was produced from the Link Market Services Meeting System
Page 1 of 1
Share your feedback
Discover